JPRN-UMIN000003922已完成未知
SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning blood pressure based on amlodipine treatment - SPEED study
SPEED investigators0 个研究点目标入组 250 人开始时间: 2010年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •allergy with ARB or amlodipine pregnancy severe liver dysfunction severe kidney dysfunction taking another antihypertensive agents patients who are not recomended Ca channel blocker as the first choice
研究者
相似试验
尚未招募
4 期
Randomized clinical trial on efficacy of telmisartan compared to vitamin E on histopathological improvement in patients with nonalcoholic steatohepatitis.onalcoholic steatohepatitis (NASH)SLCTR/2016/013Bangabandhu Sheikh Mujib Medical University
招募中
不适用
Therapeutic efficacy and safety of telmisartan in patients with non-alcoholic fatty liver disease (NAFLD) and hypertension: exploratory researchon-alcoholic fatty liver disease and hypertensionJPRN-UMIN000020537Department of General Internal Medicine, Kyushu University Hospital50
已完成
不适用
Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential HypertensionHypertensionNCT00638911Boehringer Ingelheim33,247
已完成
4 期
INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic NephropathyDiabetic NephropathiesNCT00153088Boehringer Ingelheim527
进行中（未招募）
不适用
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz